Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity

Research output: Journal contributionsJournal articlesResearchpeer-review

Standard

Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity. / Arab, Amina; Kümmerer, Klaus; Wang, Jin et al.
In: The Journal of Pharmacology and Experimental Therapeutics, Vol. 325, No. 2, 05.2008, p. 417-424.

Research output: Journal contributionsJournal articlesResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{c699c7bbea434908a2afc3e1ad535b85,
title = "Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity",
abstract = "Perfluorochemicals (PFCs) are known to provide a unique tool for controlled uptake and delivery of oxygen. We have characterized the effects of incremental oxygen delivery on cell viability of human ischemic cardiomyocytes using chemically inert PFCs as oxygen carrier. We have found that cell viability after prolonged ischemia depends on the dose of oxygen supplementation by oxygenated (ox) PFCs during reoxygenation. Although reoxygenation with the transient addition of oxPFCs in high concentrations (2250 μM O2 in 0.4 μM PFCs) results in decreased cell viability compared with normoxic reoxygenation, cell survival increases by 30 ± 4% after reoxygenation with moderate oxPFC concentrations (750 μM O2 in 0.1 μM PFCs). Immunoblot analysis revealed that oxPFC-supplemented reoxygenation causes marked (16-fold) deactivation of death-associated protein kinase (DAPK) signaling an increase in mitochondrial membrane potential and a decreased steady-state level of superoxide by 19 ± 3%. Reoxygenation with oxPFCs is further responsible for a 2-fold activation of AMP-activated protein kinase (AMPK) signaling an inadequate ATP supply by oxidative phosphorylation during reoxygenation. Addition of oxPFCs stabilizes both hypoxia-inducible factor (HIF) 1-α and 2-α during reoxygenation. Overall, these results indicate that moderate doses of oxPFCs can improve cell survival during reoxygenation, causing deactivation of DAPK, up-regulation of AMPK, and HIF1-α and 2-α stabilization. These effects of oxPFCs are dose-dependent, and they lead to a stabilization of the mitochondrial membrane potential, decreased steady-state levels of superoxide, and pacification of mitochondrial activity. Copyright {\textcopyright} 2008 by The American Society for Pharmacology and Experimental Therapeutics.",
keywords = "AMP- activated protein kinase, cell viability, death-associated protein kinase, hypoxia-inducible factor, mitochondria, perfluorochemical, Chemistry",
author = "Amina Arab and Klaus K{\"u}mmerer and Jin Wang and Christoph Bode and Christoph Hehrlein",
year = "2008",
month = may,
doi = "10.1124/jpet.107.133710",
language = "English",
volume = "325",
pages = "417--424",
journal = "The Journal of Pharmacology and Experimental Therapeutics",
issn = "1521-0103",
publisher = "Elsevier Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Oxygenated Perfluorochemicals Improve Cell Survival during Reoxygenation by Pacifying Mitochondrial Activity

AU - Arab, Amina

AU - Kümmerer, Klaus

AU - Wang, Jin

AU - Bode, Christoph

AU - Hehrlein, Christoph

PY - 2008/5

Y1 - 2008/5

N2 - Perfluorochemicals (PFCs) are known to provide a unique tool for controlled uptake and delivery of oxygen. We have characterized the effects of incremental oxygen delivery on cell viability of human ischemic cardiomyocytes using chemically inert PFCs as oxygen carrier. We have found that cell viability after prolonged ischemia depends on the dose of oxygen supplementation by oxygenated (ox) PFCs during reoxygenation. Although reoxygenation with the transient addition of oxPFCs in high concentrations (2250 μM O2 in 0.4 μM PFCs) results in decreased cell viability compared with normoxic reoxygenation, cell survival increases by 30 ± 4% after reoxygenation with moderate oxPFC concentrations (750 μM O2 in 0.1 μM PFCs). Immunoblot analysis revealed that oxPFC-supplemented reoxygenation causes marked (16-fold) deactivation of death-associated protein kinase (DAPK) signaling an increase in mitochondrial membrane potential and a decreased steady-state level of superoxide by 19 ± 3%. Reoxygenation with oxPFCs is further responsible for a 2-fold activation of AMP-activated protein kinase (AMPK) signaling an inadequate ATP supply by oxidative phosphorylation during reoxygenation. Addition of oxPFCs stabilizes both hypoxia-inducible factor (HIF) 1-α and 2-α during reoxygenation. Overall, these results indicate that moderate doses of oxPFCs can improve cell survival during reoxygenation, causing deactivation of DAPK, up-regulation of AMPK, and HIF1-α and 2-α stabilization. These effects of oxPFCs are dose-dependent, and they lead to a stabilization of the mitochondrial membrane potential, decreased steady-state levels of superoxide, and pacification of mitochondrial activity. Copyright © 2008 by The American Society for Pharmacology and Experimental Therapeutics.

AB - Perfluorochemicals (PFCs) are known to provide a unique tool for controlled uptake and delivery of oxygen. We have characterized the effects of incremental oxygen delivery on cell viability of human ischemic cardiomyocytes using chemically inert PFCs as oxygen carrier. We have found that cell viability after prolonged ischemia depends on the dose of oxygen supplementation by oxygenated (ox) PFCs during reoxygenation. Although reoxygenation with the transient addition of oxPFCs in high concentrations (2250 μM O2 in 0.4 μM PFCs) results in decreased cell viability compared with normoxic reoxygenation, cell survival increases by 30 ± 4% after reoxygenation with moderate oxPFC concentrations (750 μM O2 in 0.1 μM PFCs). Immunoblot analysis revealed that oxPFC-supplemented reoxygenation causes marked (16-fold) deactivation of death-associated protein kinase (DAPK) signaling an increase in mitochondrial membrane potential and a decreased steady-state level of superoxide by 19 ± 3%. Reoxygenation with oxPFCs is further responsible for a 2-fold activation of AMP-activated protein kinase (AMPK) signaling an inadequate ATP supply by oxidative phosphorylation during reoxygenation. Addition of oxPFCs stabilizes both hypoxia-inducible factor (HIF) 1-α and 2-α during reoxygenation. Overall, these results indicate that moderate doses of oxPFCs can improve cell survival during reoxygenation, causing deactivation of DAPK, up-regulation of AMPK, and HIF1-α and 2-α stabilization. These effects of oxPFCs are dose-dependent, and they lead to a stabilization of the mitochondrial membrane potential, decreased steady-state levels of superoxide, and pacification of mitochondrial activity. Copyright © 2008 by The American Society for Pharmacology and Experimental Therapeutics.

KW - AMP- activated protein kinase

KW - cell viability

KW - death-associated protein kinase

KW - hypoxia-inducible factor

KW - mitochondria

KW - perfluorochemical

KW - Chemistry

UR - http://www.scopus.com/inward/record.url?scp=42449097233&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.133710

DO - 10.1124/jpet.107.133710

M3 - Journal articles

C2 - 18305017

VL - 325

SP - 417

EP - 424

JO - The Journal of Pharmacology and Experimental Therapeutics

JF - The Journal of Pharmacology and Experimental Therapeutics

SN - 1521-0103

IS - 2

ER -

DOI

Recently viewed

Researchers

  1. Simon Trockel

Publications

  1. Constructing the European Space Policy
  2. Proletarische und bürgerliche Jünglinge in der Moderne
  3. Mediengestütze Elternarbeit - ein Überblick
  4. Effect of die design on the welding quality during solid state recycling of AA6060 chips by hot extrusion
  5. Toward Learning Distributions of Distributions
  6. Article 68 CISG
  7. Künstliche Tiere
  8. Strategisches Management in KMU
  9. In vivo degradability and biocompatibility of a rheo-formed Mg–Zn–Sr alloy for ureteral implantation
  10. Die Erfindung der Lithographie in technikgeschichtlicher Hinsicht
  11. Key Competencies:
  12. The case for risk-based premiums in public health insurance
  13. Einführung in die Kindheitsforschung
  14. Erinnerungsakte.
  15. Tourismusräume
  16. Bilanz machen!
  17. Ästhetik x Dispositiv
  18. Democratization as the growth of freedom
  19. From being there to being aware
  20. The Relationship of Environmental and Economic Performance at the Firm Level
  21. Geographische Restrukturierung internationaler Wertschöpfungsketten
  22. Sustainability Reporting Guidelines 2002
  23. Investigating Junior High School Students' Length Estimation Ability and Strategies
  24. (Un)Mind the gap
  25. Handwerksreform 2004
  26. Einleitung EUV/AEUV
  27. Nomenclature of organic polycycles out of the computer - how to escape the jungle of the secondary bridges.
  28. Historical emissions of octachlorodibenzodioxin in a watershed in Queensland, Australia
  29. Sonstige geldwerte Leistungen
  30. The Contemplative Conditions of a Moral Action
  31. Concentrations in ambient air and emissions of cyclic volatile methylsiloxanes in Zurich, Switzerland
  32. A klímavédelem alapvető feladatai
  33. Glen Mills Schools
  34. Spent mushroom substrate and sawdust to produce mycelium-based thermal insulation composites
  35. Junge Generation
  36. Traumziel Nachhaltigkeit
  37. Das Rauschen der Schwärme